Synucleins Antagonize Endoplasmic Reticulum Function to Modulate Dopamine Transporter Trafficking

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Oaks, Adam W ^a   Marsh Armstrong, Nicholas ^b,c   Jones, Jessica M ^a   Credle, Joel J ^a   Sidhu, Anita ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; DOPAMINE TRANSPORTER; GAMMA SYNUCLEIN;

ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELL SURFACE; DOPAMINERGIC TRANSMISSION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SECRETORY PATHWAY;

BRAIN; CELL LINE; CELL MEMBRANE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GOLGI APPARATUS; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; SYNUCLEINS; TRANSFECTION;

EID: 84881507837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070872     Document Type: Article

References (75)

1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
2. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding [alpha]-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
3. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173.
4. Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, et al. (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63: 743-750.
5. Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312.
6. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, et al. (1997) [alpha]-Synuclein in Lewy bodies. Nature 388: 839-840.
7. Galvin JE, Uryu K, Lee VM, Trojanowski JQ, (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 96: 13450-13455.
8. Surgucheva I, McMahan B, Ahmed F, Tomarev S, Wax MB, et al. (2002) Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J Neurosci Res 68: 97-106.
9. Nguyen JV, Soto I, Kim KY, Bushong EA, Oglesby E, et al. (2011) Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc Natl Acad Sci U S A 108: 1176-1181.
10. Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OM, (2007) Gamma-synuclein and the progression of cancer. FASEB J 21: 3419-3430.
11. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, et al. (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329: 1663-1667.
12. Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, et al. (2010) Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging 31: 796-804.
13. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
14. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22: 8797-8807.
15. Chandra S, Fornai F, Kwon HB, Yazdani U, Atasoy D, et al. (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A 101: 14966-14971.
16. Yavich L, Tanila H, Vepsalainen S, Jakala P, (2004) Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci 24: 11165-11170.
17. Yavich L, Jakala P, Tanila H, (2006) Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J Neurochem 99: 724-732.
18. Senior SL, Ninkina N, Deacon R, Bannerman D, Buchman VL, et al. (2008) Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. European Journal of Neuroscience 27: 947-957.
19. Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, et al. (2010) A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS One 5: e11464.
20. Anwar S, Peters O, Millership S, Ninkina N, Doig N, et al. (2011) Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci 31: 7264-7274.
21. Oaks AW, Sidhu A, (2011) Synuclein modulation of monoamine transporters. FEBS Lett 585: 1001-1006.
22. Jeannotte AM, McCarthy JG, Redei EE, Sidhu A, (2009) Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology 34: 987-998.
23. Jeannotte AM, Sidhu A, (2008) Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons. J Neurochem 105: 1668-1682.
24. Wersinger C, Rusnak M, Sidhu A, (2006) Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci 24: 55-64.
25. Wersinger C, Sidhu A, (2009) Partial regulation of serotonin transporter function by gamma-synuclein. Neurosci Lett 453: 157-161.
26. Lee FJ, Liu F, Pristupa ZB, Niznik HB, (2001) Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15: 916-926.
27. Gosavi N, Lee H-J, Lee JS, Patel S, Lee S-J, (2002) Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J Biol Chem 277: 48984-48992.
28. Wersinger C, Sidhu A, (2005) Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry 44: 13612-13624.
29. Wersinger C, Sidhu A, (2003) Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett 340: 189-192.
30. Adamczyk A, Kazmierczak A, Strosznajder JB, (2006) [alpha]-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes: Relationship to nitric oxide. Neurochemistry International 49: 407-412.
31. Fountaine TM, Wade-Martins R, (2007) RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J Neurosci Res 85: 351-363.
32. Chadchankar H, Ihalainen J, Tanila H, Yavich L (2011) Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein. Brain Res.
33. Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al. (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99: 14524-14529.
34. Boyer F, Dreyer JL, (2007) Alpha-synuclein in the nucleus accumbens induces changes in cocaine behaviour in rats. European Journal of Neuroscience 26: 2764-2776.
35. Jeannotte AM, Sidhu A, (2007) Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. Eur J Neurosci 26: 1509-1520.
36. Gonzalez MI, Susarla BT, Fournier KM, Sheldon AL, Robinson MB, (2007) Constitutive endocytosis and recycling of the neuronal glutamate transporter, excitatory amino acid carrier 1. J Neurochem 103: 1917-1931.
37. Wills J, Credle J, Oaks AW, Duka V, Lee JH, et al. (2012) Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. PLoS One 7: e30745.
38. Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, et al. (2006) Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. FASEB J 20: 2302-2312.
39. Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, et al. (2010) Alpha-synuclein delays ER-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol Biol Cell 21: 1850-1863.
40. Holden P, Horton WA, (2009) Crude subcellular fractionation of cultured mammalian cell lines. BMC Res Notes 2: 243.
41. Verhaar R, Drukarch B, Bol JG, Jongenelen CA, Musters RJ, et al. (2012) Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease. Neurobiol Dis 45: 839-850.
42. Matthies H, Han Q, Shields A, Wright J, Moore J, et al. (2009) Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neuroscience 10: 65.
43. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, et al. (2004) A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 24: 4070-4081.
44. Bland JM, Altman DG, (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
45. Pena-Oliver Y, Buchman VL, Stephens DN, (2010) Lack of involvement of alpha-synuclein on unconditioned anxiety in mice. Behav Brain Res 209: 234-240.
46. Wersinger C, Prou D, Vernier P, Sidhu A, (2003) Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 17: 2151-2153.
47. Wersinger C, Prou D, Vernier P, Niznik HB, Sidhu A, (2003) Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol Cell Neurosci 24: 91-105.
48. Wersinger C, Vernier P, Sidhu A, (2004) Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Biochemistry 43: 1242-1253.
49. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, et al. (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467-475.
50. Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, et al. (2003) Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem 278: 11753-11759.
51. Snyder H, Mensah K, Hsu C, Hashimoto M, Surgucheva IG, et al. (2005) beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. J Biol Chem 280: 7562-7569.
52. Melikian HE, Buckley KM, (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19: 7699-7710.
53. Adkins EM, Samuvel DJ, Fog JU, Eriksen J, Jayanthi LD, et al. (2007) Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. Biochemistry 46: 10484-10497.
54. Lippincott-Schwartz J, Roberts TH, Hirschberg K, (2000) Secretory protein trafficking and organelle dynamics in living cells. Annu Rev Cell Dev Biol 16: 557-589.
55. Reits EA, Neefjes JJ, (2001) From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol 3: E145-147.
56. Li JY, Henning Jensen P, Dahlstrom A, (2002) Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 113: 463-478.
57. Nehls S, Snapp EL, Cole NB, Zaal KJ, Kenworthy AK, et al. (2000) Dynamics and retention of misfolded proteins in native ER membranes. Nat Cell Biol 2: 288-295.
58. Diaz-Corrales FJ, Miyazaki I, Asanuma M, Ruano D, Rios RM, (2011) Centrosomal aggregates and Golgi fragmentation disrupt vesicular trafficking of DAT. Neurobiol Aging 33: 2462-2477.
59. Presley JF, Cole NB, Schroer TA, Hirschberg K, Zaal KJ, et al. (1997) ER-to-Golgi transport visualized in living cells. Nature 389: 81-85.
60. Lashuel HA, Hirling H, (2006) Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease. ACS Chem Biol 1: 420-424.
61. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, et al. (2006) alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313: 324-328.
62. Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, et al. (2008) The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 105: 145-150.
63. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, et al. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65: 66-79.
64. González MI, Robinson MB, (2004) Neurotransmitter transporters: why dance with so many partners? Current Opinion in Pharmacology 4: 30-35.
65. Eriksen J, Jorgensen TN, Gether U, (2010) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J Neurochem 113: 27-41.
66. Li L-B, Chen N, Ramamoorthy S, Chi L, Cui X-N, et al. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279: 21012-21020.
67. Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, et al. (2012) Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther 20: 1327-1337.
68. Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, et al. (2011) Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease. J Neurochem 116: 588-605.
69. Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, et al. (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32: 3306-3320.
70. Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, et al. (2012) Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci 32: 3301-3305.
71. Sung YH, Eliezer D, (2006) Secondary structure and dynamics of micelle bound beta- and gamma-synuclein. Protein Science 15: 1162-1174.
72. Souza JM, Giasson BI, Lee VM, Ischiropoulos H, (2000) Chaperone-like activity of synucleins. FEBS Lett 474: 116-119.
73. Cervinski MA, Foster JD, Vaughan RA, (2010) Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 170: 408-416.
74. Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, et al. (2010) alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107: 19573-19578.
75. Garcia-Reitbock P, Anichtchik O, Bellucci A, Iovino M, Ballini C, et al. (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 133: 2032-2044.